Generation of an induced pluripotent stem cell line (DHMCi009-A) from an individual with TUBB2A tubulinopathy

TUBB2A tubulinopathy is a rare neurodevelopmental disorder with developmental delay, epilepsy, and less frequent malformations of cortical development compared to other tubulinopathies. Peripheral blood mononuclear cells (PBMCs) from a male subject harboring the heterozygous de novo TUBB2A variant c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schröter, Julian (VerfasserIn) , Syring, Hanna (VerfasserIn) , Göring, Gudrun (VerfasserIn) , Kölker, Stefan (VerfasserIn) , Opladen, Thomas (VerfasserIn) , Hoffmann, Georg F. (VerfasserIn) , Syrbe, Steffen (VerfasserIn) , Jung-Klawitter, Sabine (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2 August 2022
In: Stem cell research
Year: 2022, Jahrgang: 64, Pages: 1-5
ISSN:1876-7753
DOI:10.1016/j.scr.2022.102879
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.scr.2022.102879
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1873506122002288
Volltext
Verfasserangaben:JulianSchröter, Hanna Syring, Gudrun Göhring, Stefan Kölker, Thomas Opladen, Georg F. Hoffmann, Steffen Syrbe, Sabine Jung-Klawitter
Beschreibung
Zusammenfassung:TUBB2A tubulinopathy is a rare neurodevelopmental disorder with developmental delay, epilepsy, and less frequent malformations of cortical development compared to other tubulinopathies. Peripheral blood mononuclear cells (PBMCs) from a male subject harboring the heterozygous de novo TUBB2A variant c.[743C>T] (p.[Ala248Val]) were reprogrammed to induced pluripotent stem cells (iPSCs) using the CytoTune™-iPS 2.0 Sendai Reprogramming Kit (Invitrogen). Generated iPSCs showed a normal karyotype, expression of pluripotency markers, spontaneous in vitro differentiation in all three germ layers, and are a suitable human disease model to analyze pathomechanisms underlying TUBB2A tubulinopathy and potential therapeutic targets.
Beschreibung:Online verfügbar 29 July 2022, Version des Artikels 2 August 2022
Gesehen am 20.10.2022
Beschreibung:Online Resource
ISSN:1876-7753
DOI:10.1016/j.scr.2022.102879